“The Defense Department’s F-35 Joint Strike Fighter (JSF) is one of three aircraft programs at the center of current debate over tactical aviation, the others being the Air Force F-22A fighter and the Navy F/A-18E/F fighter/attack plane,” explains a newly updated Congressional Research Service (CRS) report.
“The JSF program is a major issue in Congress because of concerns about its cost and budgetary impact, effects on the defense industrial base, and implications for U.S. national security in the early 21st century.”
Each of those matters is explored by CRS in “F-35 Joint Strike Fighter (JSF) Program: Background, Status, and Issues” (pdf), updated June 2, 2006.
See also “Proposed Termination of Joint Strike Fighter (JSF) F136 Alternate Engine” (pdf), April 13, 2006.
Congress does not permit direct public access to products of the Congressional Research Service.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.